Copper-dependent co-internalization of the prion protein and glypican-1

Journal of Neurochemistry

Volumn 98, Issue 5, 2006, Pages 1445-1457

  Cheng, Fang ^a   Lindqvist, Josefin ^a   Haigh, Cathryn L ^b   Brown, David R ^b   Mani, Katrin ^a  

^a LUND UNIVERSITY   (Sweden)

^b University of Bath   (United Kingdom)

Author keywords

Copper; Glypican; Heparan sulfate; Nitric oxide; Prion

Indexed keywords

AMYLOID; ASCORBIC ACID; CAVEOLIN; COPPER ION; CYSTEINE DERIVATIVE; GLYCOSAMINOGLYCAN; GLYCOSYLPHOSPHATIDYLINOSITOL; GLYPICAN; GLYPICAN 1; HEPARAN SULFATE; ISOPROTEIN; NITRIC OXIDE; NITRIC OXIDE DONOR; PRION PROTEIN; PROTEOGLYCAN; REDUCING AGENT; THIOL GROUP; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CATALYSIS; CELL COMPARTMENTALIZATION; CELL NUCLEUS; CELL SURFACE; CONFOCAL MICROSCOPY; DEAMINATION; ENDOCYTOSIS; EXPOSURE; FIBROBLAST; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOMAGNETIC SEPARATION; INTERNALIZATION; MOUSE; NITROSYLATION; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN METABOLISM; TECHNIQUE;

ANIMALS; BLOTTING, WESTERN; CAVEOLIN 1; CELL LINE, TUMOR; COPPER; CYTOSOL; FLUORESCENT ANTIBODY TECHNIQUE; GREEN FLUORESCENT PROTEINS; HEPARAN SULFATE PROTEOGLYCANS; HEPARITIN SULFATE; IMMUNOMAGNETIC SEPARATION; IMMUNOPRECIPITATION; MICE; NEUROBLASTOMA; NITRIC OXIDE; PRIONS; PROTEIN TRANSPORT; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 33746919587     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.03981.x     Document Type: Article

References (45)

1. Aguzzi A. and Polymenidou M. (2004) Mammalian prion biology: one century of evolving concepts. Cell 116, 313-327.
2. Brown D. R. (1999) Prion protein expression aids cellular uptake and veratridine-induced release of copper. J. Neurosci. Res. 58, 717-725.
3. Brown D. R. (2001) Prion and prejudice: normal protein at the synapse. Trends Neurosci. 24, 85-90.
4. Brown L. R. and Harris D. A. (2003) Copper and zinc cause delivery of the prion protein from the plasma membrane to a subset of early endosomes and the Golgi. J. Neurochem. 87, 353-363.
5. Brown D. R., Qin K., Herms J. W. et al. (1997) The cellular prion protein binds copper in vivo. Nature 390, 684-687.
6. Brown D. R., Wong B. S., Hafiz F., Clive C., Haswell S. and Jones I. M. (1999) Normal prion protein has an activity like that of superoxide dismutase. Biochem. J. 344, 1-5.
7. Cashman N. R. and Caughey B. (2004) Prion diseases - close to effective therapy? Nature Rev. Drug Discov. 3, 874-884.
8. Cheng F., Mani K., van den Born J., Ding K., Belting M. and Fransson L. Å. (2002) Nitric oxide-dependent processing of heparan sulfate in recycling S-nitrosylated glypican-1 takes place in caveolin-1-containing endosomes. J. Biol. Chem. 277, 44 431-44 439.
9. Ding K., Sandgren S., Mani K., Belting M. and Fransson L. Å. (2001) Modulations of glypican-1 heparan sulfate structure by inhibition of endogenous polyamine synthesis. Mapping of spermine-binding sites and heparanase, heparin lyase, and nitric oxide/nitrite cleavage sites. J. Biol. Chem. 276, 46 779-46 791.
10. Ding K., Mani K., Cheng F., Belting M. and Fransson L. Å. (2002) Copper-dependent autocleavage of glypican-1 heparan sulfate by nitric oxide derived from intrinsic nitrosothiols. J. Biol. Chem. 277, 33 353-33 360.
11. Elimova E., Kisilevsky R., Szarek W. A. and Ancsin J. B. (2004) Amyloidogenesis recapitulated in cell culture: a peptide inhibitor provides direct evidence for the role of heparan sulfate and suggests a new treatment strategy. FASEB J. 14, 1749-1751.
12. Fivaz M., Vilbois F., Thurnheer S., Pasquali C., Abrami L., Bickel P. E., Parton R. G. and van der Goot F. G. (2002) Differential sorting and fate of endocytosed GPI-anchored proteins. EMBO J. 15, 3989-4000.
13. Franch-Marro X., Marchand O., Piddini E., Ricardo S., Alexandre C. and Vincent J. P. (2005) Glypicans shunt the Wingless signal between local signalling and further transport. Development 132, 659-666.
14. Fransson L. Å., Belting M., Cheng F., Jönsson M., Mani K. and Sandgren S. (2004) Novel aspects of glypican glycobiology. Cell. Mol. Life Sci. 61, 1016-1024.
15. Harmey J. H., Doyle D., Brown V. and Rogers M. S. (1995) The cellular isoform of the prion protein, PrPc, is associated with caveolae in mouse neuroblastoma (N2a) cells. Biochem. Biophys. Res. Commun. 210, 753-759.
16. Hijazi N., Kariv-Inbal Z., Gasset M. and Gabizon R. (2005) PrPSc incorporation to cells requires endogenous glycosaminoglycan expression. J. Biol. Chem. 17, 17 057-17 061.
17. Holme A., Daniels M., Sassoon J. and Brown D. R. (2003) A novel method of generating neuronal Holme cell lines from gene-knockout mice to study prion protein membrane orientation. Eur. J. Neurosci. 18, 571-579.
18. Horonchik L., Tzaban S., Ben-Zaken O., Yedidia Y., Rouvinski A., Papy-Garcia D., Barritault D., Vlodavsky I. and Taraboulos A. (2005) Heparan sulfate is a cellular receptor for purified infectious prions. J. Biol. Chem. 280, 17 062-17 067.
19. Kaneko K., Vey M., Scott M., Pilkuhn S., Cohen F. E. and Prusiner S. B. (1997) COOH-terminalsequence of the cellular prion protein directs subcellular trafficking and controls conversion into the scrapie isoform. Proc. Natl Acad. Sci. USA 94, 2333-2338.
20. Keshet G. I., Ovadia H., Taraboulos A. and Gabizon R. (1999) Scrapie-infected mice and PrP knockout mice share abnormal localization and activity of neuronal nitric oxide synthase. J. Neurochem. 72, 1224-1231.
21. Lee K. S., Magalhaes A. C., Zanata S. M., Brentani R. R., Martins V. R. and Prado M. A. M. (2001) Internalization of mammalian fluorescent cellular prion protein and N-terminal deletion mutants in living cells. J. Neurochem. 79, 79-87.
22. Mange A., Milhavet O., Umlauf D., Harris D. and Lehmann S. (2002) PrP-dependent cell adhesion in N2a neuroblastoma cells. FEBS Lett. 514, 159-162.
23. Mani K., Jonsson M., Edgren G., Belting M. and Fransson L. Å. (2000) A novel role for nitric oxide in the endogenous degradation of heparan sulfate during recycling of glypican-1 in vascular endothelial cells. Glycobiology 6, 577-586.
24. Mani K., Cheng F., Havsmark B., Jönsson M., Belting M. and Fransson L. Å. (2003) Prion, amyloid beta-derived Cu (II) ions, or free Zn (II) ions support S-nitroso-dependent autocleavage of glypican-1 heparan sulfate. J. Biol. Chem. 278, 38 956-38 965.
25. Marella M., Lehmann S., Grassi J. and Chabry J. (2002) Filipin prevents pathological prion protein accumulation by reducing endocytosis and inducing cellular PrP release. J. Biol. Chem. 277, 25 457-25 464.
26. Martins V. R., Linden R., Pardo M. A. M., Walz R., Sakamoto A. C., Izquierdo I. and Brentani R. R. (2002) Cellular prion protein: on the road for functions. FEBS Lett. 512, 25-28.
27. McBride P. A., Wilson M. I., Eikelenboom P., Tunstall A. and Bruce M. E. (1998) Heparan sulfate proteoglycan is associated with amyloid plaques and neuroanatomically targeted PrP pathology throughout the incubation period of scrapie-infected mice. Exp. Neurol. 149, 447-454.
28. Millhauser G. L. (2004) Copper binding in the prion protein. Acc. Chem. Res. 2, 79-85.
29. Mouillet-Richard S., Ermonval M., Chebassier C., Laplanche J. L., Lehmann S., Launay J. M. and Kellermann O. (2000) Signal transduction through prion protein. Science 289, 1925-1928.
30. Nichols B. (2003) Caveosomes and endocytosis of lipid rafts. J. Cell. Sci. 116, 4707-4714.
31. Pauly P. C. and Harris D. A. (1998) Copper stimulates endocytosis of the prion protein. J. Biol. Chem. 273, 33 107-33 110.
32. Pelkmans L. and Helenius A. (2002) Endocytosis via caveolae. Traffic 3, 311-320.
33. Peters P. J., Mironov A., Peretz D., van Donselaar E., Leclerc E., Erpel S., DeArmond S. J., Burton D. R., Williamson R. A., Vey M. and Prusiner S. B. (2003) Trafficking of prion proteins through a caveolae-mediated endosomal pathway. J. Cell. Biol. 162, 703-717.
34. Priola S. A. and Caughey B. (1994) Inhibition of scrapie-associated PrP accumulation. Probing the role of glycosaminoglycans in amyloidogenesis. Mol. Neurobiol. 8, 113-120.
35. Prusiner S. B. (1998) Prions. Proc. Natl Acad. Sci. USA 95, 13 363-13 383.
36. Qin K., Yang Y., Mastrangelo P. and Westaway D. (2002) Mapping Cu (II) bindingsites in prion proteins by diethyl pyrocarbonate modification and matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometric footprinting. J. Biol. Chem. 277, 1981-1990.
37. Schonberger O., Horonchik L., Gabizon R., Papy-Garcia D., Barritault D. and Taraboulos A. (2003) Novel heparan mimetics potently inhibit the scrapie prion protein and its endocytosis. Biochem. Biophys. Res. Commun. 312, 473-479.
38. Shyng S. L., Moulder K. L., Lesko A. and Harris D. A. (1995) The N-terminal domain of a glycolipid-anchored prion protein is essential for its endocytosis via clathrin-coated pits. J. Biol. Chem. 270, 14 793-14 800.
39. Sunyach C., Jen A., Deng J., Fitzgerald K. T., Frobert Y., Grassi J., McCaffrey M. W. and Morris R. (2003) The mechanism of internalization of glycosylphosphatidylinositol-anchored prion protein. EMBO J. 22, 3591-3601.
40. Tkachenko E., Rhodes J. M. and Simons M. (2005) Syndecans: new kids on the signaling block. Circ. Res. 96, 488-500.
41. Vey M., Pilkuhn S., Wille H., Nixon R., DeArmond S., Smart E. J., Anderson R. G. W., Taraboulos A. and Prusiner S. B. (1996) Subcellular colocalization of the cellular and scrapie prion proteins in caveolae-like membranous domains. Proc. Natl Acad. Sci. USA 93, 14 945-14 949.
42. Viles J. H., Cohen F. E., Prusiner S. B., Goodin D. B., Wright P. E. and Dyson H. J. (1999) Copper binding to the prion protein: structural implications of four identical cooperative binding sites. Proc. Natl Acad. Sci. USA 96, 2042-2047.
43. Warner R. G., Hundt C., Weiss S. and Turnbull J. E. (2002) Identification of the heparan sulfate binding sites in the cellular prion protein. J. Biol. Chem. 277, 18421-18430.
44. Watanabe N., Araki W., Chui D. H., Makifuchi T., Ihara Y. and Tabira. T. (2004) Glypican-1 as an Abeta binding HSPG in the human brain: its localization in DIG domains and possible roles in the pathogenesis of Alzheimer's disease. FASEB J. 18, 1013-1015.
45. Zimmermann P., Zhang Z., Degeest G., Mortier E., Leenaerts I., Coomans C., Schulz J., N'Kuli F., Courtoy P. J. and David G. (2005) Syndecan recycling [corrected] is controlled by syntenin-PIP2 interaction and Arf6. Dev. Cell. 3, 377-388.